Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial
Steven E. Lipshultz(Jacobs Institute), Steven D. Colan(Boston Children's Hospital), Marshall A. Schorin(Inova Fairfax Hospital), Luis A. Clavell(San Juan City Hospital), Eric Larsen(University of Massachusetts Chan Medical School), E. John Orav(Harvard University), Elly Barry, Uma H. Athale(McMaster University), Lewis B. Silverman(Columbia University Irving Medical Center), Albert Moghrabi(Centre Hospitalier Universitaire Sainte-Justine), Barbara L. Asselin(University of Rochester Medical Center), Stuart R. Lipsitz(Brigham and Women's Hospital), Bruno Michon(Centre hospitalier universitaire de Québec), Stephen E. Sallan, Rebecca E. Scully(Brigham and Women's Hospital), Yvan Samson(Centre hospitalier universitaire de Québec), Harvey J. Cohen(Lucile Packard Children's Hospital), Tracie L. Miller(University of Missouri–Kansas City), Donna Neuberg(Otsuka (Japan))
Cited by 452
Related Papers
Analysis of <i>Fusobacterium</i> persistence and antibiotic response in colorectal cancer
|Science|2017|1.6k
Recommendations for Quantification Methods During the Performance of a Pediatric Echocardiogram: A Report From the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council
|Journal of the American Society of Echocardiography|2010|1.5k